A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Obesity Is a Medical Condition and Not a Personal Fault: New Research Report

November 3, 2020

Obesity is a major problem in the United States and Americans are beginning to understand that obesity is a medical condition, not a personal fault according to new research.

At ObesityWeek 2020 new research emerges. For this research, Ted Kyle, RPH, MBA, and a team of obesity experts surveyed a total of 7,076 adults in 2017 and 2020. They found that significantly more respondents – 42% – agreed in 2020 that people with obesity need less blame and more medical help. Only 26% disagreed. Just three short years ago, only 30% of Americans agreed with this idea and 39% disagreed.

On top of that, Kyle and his colleagues saw a big shift in attitudes about hiring people with obesity. Two-thirds of respondents in 2020 said they would interview a person with obesity for a job. In 2017, that number was significantly smaller, only 57%.

Kyle said that this is good news, “Obesity is a biological condition that is mostly inherited. A person’s genes set the table for obesity, and the environment where we all live serves it up. If a person is biologically resistant, they are unlikely to gain weight in an environment that promotes obesity. But a susceptible person will. So it makes sense to deal with this condition like any other medical condition. Find effective ways to prevent it and provide people who already have it with effective medical care to reduce the impact on health.”

Joe Nadglowski, President and CEO of the Obesity Action Coalition, was one of the co-authors of this study. He linked these findings back to the decision in 2013 by the American Medical Association to recognize that obesity is a complex, chronic disease. “Before 2013, just about everyone’s assumption was that obesity was a problem of bad choices and unhealthy behavior. But now, people are coming to realize it is more complicated than that. Simply blaming people is counterproductive. It leads to worse, not better, health. So, we’re glad to see progress toward better public understanding of obesity,” said Nadglowski.

To view the full presentation on this research visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy